Accuray Incorporated ( NASDAQ: ARAY) Shareholder/Analyst Call September 29, 2025 4:30 PM EDT ...

The PRIME trial tested whether the dynamic contrast enhancement sequence in multiparametric MRI is truly necessary to improve significant prostate cancer ...

Dr. Wallen: PSA can vary even day by day in patients for a lot of reasons. First of all, PSA is not a cancer specific test.

“For whatever reasons men might choose to not proactively seek care, it is important to educate these men that there are ...

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators found that stereotactic body radiotherapy (SBRT) ...

Scan.com offers fast, accessible private scans including MRI, CT and ultrasound, with results in days and no GP referral ...

This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...

IRISH LANGUAGE BROADCASTER TG4 has joined those paying tribute to the documentary film maker and writer Manchán Magan who has ...

New technologies are at the forefront of modern medical care, and the field of urology is a leader in this area. From the evolution of robotic surgery techniques to the integration of artificial ...

Primary physician reporting grade 2+ toxicity per CTCAE version 5.0 was the primary endpoint. Follow-up was performed 30 days post-treatment and subsequently every 3 to 4 months for 2 years: ...